Evaluating Use Patterns of a Closed Electronic Nicotine Delivery System Among Adults in the United States Who Smoke Cigarettes Daily: 8-Week Actual Use Study Background: Adults who smoke cigarettes may reduce their exposure to cigarette smoke by switching completely or partially to an electronic nicotine delivery system (ENDS). Objective: This study aimed to investigate the use patterns of a novel ENDS, over 8 weeks, among U.S. adults who smoke cigarettes daily. The objectives were to assess the proportion of participants who switched completely and any changes in cigarette consumption. Methods: This actual use study assessed the use of a novel ENDS with two variants (tobacco and menthol) among exclusive cigarette smokers (n = 353) and dual users of cigarettes/ENDS (n = 367). Use of ENDS and cigarettes was reported daily during a 1-week baseline and during an 8-week observational period, during which participants could also use the novel ENDS. Use of, complete switching to, and sensory experience of both novel ENDS variants and cigarette consumption use patterns were assessed at the end of the observational period and compared to baseline. Results: At the end of the observational period, over 85% of both study groups used the novel ENDS and 4% switched completely. Additionally, 25% of both study groups reduced their cigarette consumption by 50% or more. A higher proportion of participants used the menthol variant, which was also more positively evaluated in terms of taste, smell, and aftertaste than the tobacco variant. Conclusions: This study indicates that adults who smoke cigarettes daily can switch to the novel ENDS, using it exclusively or substantially reducing their cigarette consumption. These results complement the scientific evidence suggesting that ENDS are an acceptable alternative to cigarette smoking among adults who would otherwise continue to smoke.

JMIR Formative Res: Evaluating Use Patterns of a Closed Electronic Nicotine Delivery System Among Adults in the United States Who Smoke Cigarettes Daily: 8-Week Actual Use Study #ElectronicCigarettes #ENDS #SmokingAlternatives #CigaretteSmoking #NicotineDelivery

Altria beats quarterly estimates on robust nicotine pouch demand (Reuters) -Tobacco giant Altria (NYSE:MO) beat Wall Street estimates for second-quarter revenue and profit on Wednesday, helped by strong demand for its on! nicotine pouches. The Richmond, Virginia-based company has been banking on its portfolio of smoking alternatives, such as nicotine pouches, to offset the impact from lost sales as more consumers move away from traditional cigarettes and chewing tobacco. While sales of Altria’s vape brand, NJOY, were halted earlier this year amid a patent dispute, higher growth at its on! segment helped make up for the collapse in sales. The company had said in April NJOY will not return to the market this year, booking a hefty impairment related to its vape unit. Widespread sales of unregulated disposable vapes, mostly from China, have eaten into vape and traditional tobacco businesses in the U.S. However, Altria said it anticipates a limited benefit from higher seizures of such devices. The company’s quarterly revenue including excise taxes rose 0.2% to $5.29 billion from a year ago, compared with analysts’ average estimate of a 1.8% decline to $5.18 billion, according to data compiled by LSEG Its adjusted second-quarter profit of $1.44 per share beat estimates of $1.39. Shipment volume for on! nicotine pouches rose 26.5%, compared with a 13.7% increase a year ago. Rival Philip Morris International (NYSE:PM)’s shares suffered last week after shipments of its ZYN nicotine pouches - by far the No. 1 pouch brand in the U.S. - came in below expectations. Shipment volume for Altria’s smokeable tobacco business fell 10.2% during the second quarter, compared with a 13% decline a year ago. The company recorded a non-cash, pre-tax charge of $354 million during the quarter, related to an impairment of trademark for its Skoal smokeless tobacco. It did not give a reason for the impairment. Altria expects annual adjusted earnings of $5.35 to $5.45 per share, compared with previous expectations of $5.30 to $5.45.

Click Subscribe #Altria #nicotine #smokingalternatives #tobaccoindustry #vape

Just released: Portable single-use vapes that hit 18,000 puffs - perfect for on-the-go smokers! #VapeNews #SmokingAlternatives 🚬⚡ Perfume for women: cutt.ly/mrRd3nMy